Skip to main content

Table 2 Fold changes in expressions of up regulated miRNAs and its relevance with published reports

From: MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance

 

1wk CSFBS ∆ change

1wk CDX ∆ change

3wks CSFBS ∆ change

3wk CDX ∆ change

Expression in other Cancer

References

hsa-let-7f-1

12.50

12.17

13.91

17.64

[42, 43]

hsa-miR-136

3.69

3.44

5.16

4.30

[44, 45]

hsa-miR-143

15.80

19.67

13.92

6.25

[46, 47]

hsa-miR-146a

31.44

20.83

56.46

50.68

[48, 49]

hsa-miR-218

4.64

2.33

18.44

11.49

[50, 51]

hsa-miR-22

2.39

2.43

4.58

3.10

[52]

hsa-miR-22*

15.91

11.56

11.78

22.47

NA

hsa-miR-222

3.65

1.99

7.05

4.63

[53, 54]

hsa-miR-29a

2.09

1.58

4.60

4.24

[55, 56]

hsa-miR-302a*

2.97

7.73

3.87

4.48

[57, 58]

hsa-miR-3138

6.53

5.94

6.66

5.96

-

NA

hsa-miR-3144b-5p

11.25

4.39

4.47

8.53

[59]

hsa-miR-3192

8.70

2.11

5.52

5.71

-

NA

hsa-miR-3199

1.25

4.54

2.71

6.76

-

NA

hsa-miR-34b*

3.15

2.34

6.69

8.64

[60, 61]

hsa-miR-493*

1.31

1.42

2.31

15.06

[62]

hsa-miR-548h

2.12

3.76

4.06

6.72

-

NA

hsa-miR-548l

3.94

3.11

8.66

7.40

-

NA

hsa-miR-548p

3.88

2.44

4.64

1.55

-

NA

hsa-miR-548t

4.89

9.65

1.26

5.46

-

NA

hsa-miR-664

3.81

4.01

5.16

5.05

[63]

  1. NA: Not available. *denotes the star strand, which is currently designated as -3p or -5p. Thickness of arrows represents number of publications available corresponding to the expression pattern.